NHS national Generic Pharmaceuticals Transition 2021_2
Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: Allregions: 15/06/2021 to 28/02/2022 (8.5months)Transition CESW: 15/06/2021 to30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5months)NWLN: 15/06/2021 to 31/01/2022 (7.5months)Hospital Only Housekeeping Products:All regions: 15/06/2021 to 31/01/2022 (7.5 months)
Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Value
£115,932,694
Published
4 Jun 2021
Closes
23 Feb 2021
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
33690000
Various medicinal products
Lots
Lot 6 Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions
Value not provided
Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential...
Delivery: United Kingdom
Lot 3 Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region
Value not provided
Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potenti...
Delivery: United Kingdom
Lot 4 Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions
Value not provided
Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential...
Delivery: United Kingdom
Lot 2 Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region
Value not provided
Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potenti...
Delivery: United Kingdom
Lot 1 Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region
Value not provided
Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential...
Delivery: United Kingdom
Lot 5 Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions
Value not provided
Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential...
Delivery: United Kingdom
Lot 01 Lot 1 - CM/PHG/20/5631/00 Transition Products - CESW Region
£1
NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs unde...
Delivery: United Kingdom
Lot 02 Lot 2 - CM/PHG/20/5631/00 Transition Products - LSNE Region
£1
NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs unde...
Delivery: United Kingdom
Lot 03 Lot 3 - CM/PHG/20/5631/00 Transition Products - NWLN Region
£1
NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs unde...
Delivery: United Kingdom
Lot 06 Lot 6 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions
Value not provided
NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs unde...
Delivery: United Kingdom
Lot 04 Lot 4 - CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions
£1
NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs unde...
Delivery: United Kingdom
Lot 05 Lot 5 - CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions
£1
NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs unde...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.